In the Stansberry Innovations Report, editor John Engel and our team of technology experts focus on the most pioneering and disruptive technologies around the world today. The team looks for early opportunities in new technology trends that span the medical sciences, biotechnology, software, hardware, defense, and cryptocurrencies. These trends will likely play out over several years and decades.
Before becoming editor of the Innovations Report, John worked as our in-house biotechnology analyst, regularly contributing to Stansberry Venture Technology and our flagship newsletter Stansberry's Investment Advisory.
John holds a Master of Science from Johns Hopkins University and has hands-on experience in the biotechnology industry. He has personally developed several early stage drug therapeutic candidates. He spent several years as bench scientist in a drug discovery laboratory for one of the largest pharmaceutical companies in the U.S.
Now, John uses his experience in biotechnology to identify the most innovative technology companies out there – opportunities with moderate risk but outsized upside potential.
Subscribers to Stanberry Innovations Report get access to a monthly research advisory that shows them how to invest safely in the next technology revolutions. John focuses on the most pioneering and disruptive technologies around the world today and uses his wealth of experience in mechanical engineering, molecular biology, biochemistry, and bioinformatics to identify the most innovative technology companies out there.
|
